NASSIM TASSOU

Dr. NASSIM TASSOU


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 August 2025 in Biologics
Verified
Journal Article
Open access
PDF file
NTNASSIM TASSOU
NASSIM TASSOU
HAHAJAR ANIBAT
HAJAR ANIBAT
ATAhmed Tissent
Ahmed Tissent
NHNORDDINE HABTI
NORDDINE HABTI
Background and Objectives: The cytokine IL-6, methyltransferase NSD2, pro-protein convertase Furin, and growth factor receptor IGF-1R are essential factors in the proliferation of cancer cells. These proteins are involved in the tumor process by generating several cell-signaling pathways. However, the interactions of these oncogenic biomarkers, Furin, IL-6, and NSD2, and their links with the inhibitor SERPINA-1 remain largely unknown. Materials and Methods: Cell proliferation is measured by colorimetric and enzymatic methods. The genetic expressions of SERPINA-1, Furin, IL-6, and NSD2 are measured by qRT-PCR, while the expression of IGF-1R on the cell surface is measured by flow cytometry. Results: The proliferation of cells overexpressing SERPINA-1 (JP7pSer+) is decreased by more than 90% compared to control cells (JP7pSer-). The kinetics of the gene expression ratios of Furin, IL-6, and NSD2 show an increase for 48 h, followed by a decrease after 72 h for the three biomarkers in JP7pSer+ cells compared to JP7pSer- cells. The expression of IGF-1R on the cell surface in both cell lines is low, with JP7pSer- cells expressing 1.33 times more IGF-1R than JP7pSer+ cells. Conclusions: These results suggest gene correlations of SERPINA-1 overexpression with decreased cell proliferation and modulation of gene expression of Furin, IL-6, and NSD2. This study should be complemented by molecular transcriptomic and proteomic experiments to better understand the interaction of SERPINA-1 with IL-6, Furin, and NSD2, and their effect on tumor progression.

12 June 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
NTNASSIM TASSOU
NASSIM TASSOU
HAHAJAR ANIBAT
HAJAR ANIBAT
ATAhmed Tissent
Ahmed Tissent
NHNORDDINE HABTI
NORDDINE HABTI
Background and objectives: IL-6 is a cytokine that promotes the proliferation of can-cer cells by activating the JAK/STAT pathway via STAT3, which is expressed after methylation by NSD2. Furin, a pro-protein convertase responsible for the maturation of several precursor proteins such as pro-IGF-1R, involved in the activation of PI3K/AKT and the MAPK pathway, plays a crucial role in cancer proliferation. Our objective is to observe the impact of the overexpression of SERPINA-1, an an-ti-inflammatory and serine protease inhibitor, on cell proliferation and the genetic ex-pression of IL-6, Furin, and NSD2. Materials and Methods: In hetero-hybrid lympho-blastoid cells either transfected with the SERPINA-1 gene (JP7pSer+) or without the SERPINA-1 gene (JP7pSer-); we studied by qRT-PCR the genetic overexpression of the SERPINA-1 gene and the genetic expression of Furin, IL-6, and NSD2 genes. Cell pro-liferation was tested by colorimetric and enzymatic methods, and the membrane ex-pression of IGF-1R was measured by flow cytometry. Results: The proliferation of the JP7pSer+ cell line is decreased by 91% and 85% in both measurement methods on day 6 compared to JP7pSer- cells. The kinetics of the genetic expression of Furin, IL-6, and NSD2 show an increase in expression times in JP7pSer+ cells compared to JP7pSer- cells, but after three days, this ratio is reversed. The ratio of mean fluorescence intensi-ty shows that JP7pSer- cells express 1.33 times more IGF-1R than JP7pSer+ cells. Con-clusion: These results suggest promising therapeutic avenues for cancer, which should be complemented by advanced studies on the expression of SERPINA-1 and the inter-action with the expression of IL-6 and Furin.